Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.
Evans DG, Halliday D, Obholzer R, Afridi S, Forde C, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SM, Pathmanaban ON, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Lavin T, Paterson C, Whitfield G, McCabe MG, Axon PR, Halliday J, Mackeith S, Parry A; English Specialist NF2 Research Group; Harkness EF, Buttimore J, King AT. Evans DG, et al. Among authors: kilday jp. Neurooncol Adv. 2023 Mar 11;5(1):vdad025. doi: 10.1093/noajnl/vdad025. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37051330 Free PMC article.
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Fenwick N, Weston R, Wheatley K, Hodgson J, Marshall L, Elliott M, Makin G, Ng A, Brennan B, Lowis S, Adamski J, Kilday JP, Cox R, Gattens M, Moore A, Trahair T, Ronghe M, Campbell M, Campbell H, Williams MW, Kirby M, Van Eijkelenburg N, Keely J, Scarpa U, Stavrou V, Fultang L, Booth S, Cheng P, De Santo C, Mussai F. Fenwick N, et al. Among authors: kilday jp. Front Oncol. 2024 Jan 31;14:1296576. doi: 10.3389/fonc.2024.1296576. eCollection 2024. Front Oncol. 2024. PMID: 38357205 Free PMC article.
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
O'Hare P, Cooney T, de Blank P, Gutmann DH, Kieran M, Milde T, Fangusaro J, Fisher M, Avula S, Packer R, Fukuoka K, Mankad K, Mueller S, Waanders AJ, Opocher E, Bouffet E, Raabe E, Werle NE, Azizi AA, Robison NJ, Hernáiz Driever P, Russo M, Schouten N, van Tilburg CM, Sehested A, Grill J, Bandopadhayay P, Kilday JP, Witt O, Ashley DM, Ertl-Wagner BB, Tabori U, Hargrave DR. O'Hare P, et al. Among authors: kilday jp. Neuro Oncol. 2024 May 14:noae074. doi: 10.1093/neuonc/noae074. Online ahead of print. Neuro Oncol. 2024. PMID: 38743009
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: kilday jp. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.
Green K, Panagopoulou P, D'Arco F, O'Hare P, Bowman R, Walters B, Dahl C, Jorgensen M, Patel P, Slater O, Ahmed R, Bailey S, Carceller F, Collins R, Corley E, English M, Howells L, Kamal A, Kilday JJ, Lowis S, Lumb B, Pace E, Picton S, Pizer B, Shafiq A, Uzunova L, Wayman H, Wilson S, Hargrave D, Opocher E. Green K, et al. Neuro Oncol. 2023 Apr 6;25(4):774-785. doi: 10.1093/neuonc/noac223. Neuro Oncol. 2023. PMID: 36239316 Free PMC article.
The role of artificial intelligence in paediatric neuroradiology.
Pringle C, Kilday JP, Kamaly-Asl I, Stivaros SM. Pringle C, et al. Among authors: kilday jp. Pediatr Radiol. 2022 Oct;52(11):2159-2172. doi: 10.1007/s00247-022-05322-w. Epub 2022 Mar 26. Pediatr Radiol. 2022. PMID: 35347371 Free PMC article. Review.
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA, Chapman RJ, Kilday JP, Thorp N, Modena P, Dineen RA, Macarthur D, Mallucci C, Jaspan T, Pajtler KW, Giagnacovo M, Jacques TS, Paine SML, Ellison DW, Bouffet E, Grundy RG. Ritzmann TA, et al. Among authors: kilday jp. Neuro Oncol. 2022 Jun 1;24(6):936-948. doi: 10.1093/neuonc/noac012. Neuro Oncol. 2022. PMID: 35018471 Free PMC article. Clinical Trial.
Pediatric ependymomas: destined to recur?
Ritzmann TA, Kilday JP, Grundy RG. Ritzmann TA, et al. Among authors: kilday jp. Neuro Oncol. 2021 Jun 1;23(6):874-876. doi: 10.1093/neuonc/noab066. Neuro Oncol. 2021. PMID: 33728470 Free PMC article. No abstract available.
42 results